ViewRay, Inc. announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that delivers personalized cancer care by combining the latest innovations in precision radiation delivery with ground-breaking MR-guidance. The first two patients treated at KMUH on MRIdian were provided care for prostate cancer and tumor lesions in the left lung. Both treatments took advantage of MRIdian's automated beam-gating technology, protecting surrounding organs at risk.
“Cancer doesn’t wait,” said Dr. Daniel Cagney, a radiation oncologist. “Initially in March and April, there were significant unknowns, but we’ve been living with this for a few months. ... I feel very confident that we will provide the best care for patients and it’s safe for them to come into the hospital.”
ViewRay, Inc. announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference. Scott Drake, President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020.
Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.